These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28709816)

  • 1. [Current knowledge on perioperative treatments of non-small cell lung carcinomas].
    Brosseau S; Naltet C; Nguenang M; Gounant V; Mordant P; Milleron B; Castier Y; Zalcman G
    Rev Mal Respir; 2017 Jun; 34(6):618-634. PubMed ID: 28709816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perioperative therapies in surgical non N2 non-small cell lung cancer].
    Ruppert AM; Lavolé A; Assouad J; Cadranel J; Wislez M
    Bull Cancer; 2017 Jan; 104(1):79-85. PubMed ID: 27912893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
    Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
    Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Suehisa H; Toyooka S
    Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perioperative treatment for resected non-small cell lung cancer: Which option in 2020?].
    Coureau M; Berghmans T
    Rev Mal Respir; 2021 Jan; 38(1):74-86. PubMed ID: 33402250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the extent of the advantage of video-assisted thoracoscopic surgical resection over thoracotomy in terms of delivery of adjuvant chemotherapy following non-small-cell lung cancer resection?
    Teh E; Abah U; Church D; Saka W; Talbot D; Belcher E; Black E
    Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):656-60. PubMed ID: 25015538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of postoperative adjuvant chemotherapy for completely resected non-small lung cancer].
    Tsuboi M
    Nihon Geka Gakkai Zasshi; 2014 May; 115(3):125-9. PubMed ID: 24946518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
    Alden RS; Mandrekar SJ; Oxnard GR
    Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
    Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
    Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment and prognosis of advanced stage non-small-cell lung cancer].
    Chermiti Ben Abdallah F; Ben Ali G; Sadok Boudaya M; Mlika M; Chtourou A; Taktak S; Ben Kheder A
    Rev Mal Respir; 2014 Mar; 31(3):214-20. PubMed ID: 24680112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Which treatments should be proposed in resectable stage III cancers?].
    Thibout Y; Cortot A; Chapet O; Mornex F; Milleron B
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S37-42. PubMed ID: 15536351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE.
    Wislez M; Barlesi F; Besse B; Mazières J; Merle P; Cadranel J; Audigier-Valette C; Moro-Sibilot D; Gautier-Felizot L; Goupil F; Renault A; Quoix E; Souquet PJ; Madroszyck A; Corre R; Pérol D; Morin F; Zalcman G; Soria JC
    J Clin Oncol; 2014 Apr; 32(12):1256-61. PubMed ID: 24638013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.